Jyong biotech ltd. ordinary sharesMENS.US Overview

MENS Earnings Table

• When is MENS's latest earnings report released?

  The most recent financial report for Jyong biotech ltd. ordinary shares (MENS) covers the period of 1999Q4 and was published on 1999/01/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating MENS's short-term business performance and financial health. For the latest updates on MENS's earnings releases, visit this page regularly.

• How much debt does MENS have?

  As of the end of the reporting period, Jyong biotech ltd. ordinary shares (MENS) had total debt of 18.14M, with a debt ratio of 0. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

• How much cash does MENS have?

  At the end of the period, Jyong biotech ltd. ordinary shares (MENS) held Total Cash and Cash Equivalents of 98K, accounting for 0.02 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

• Does MENS go with three margins increasing?

  In the latest report, Jyong biotech ltd. ordinary shares (MENS) achieved the “three margins increasing” benchmark, with a gross margin of 23.8%%, operating margin of 9.04%%, and net margin of 5.6%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess MENS's profit trajectory and future growth potential.